amanta healthcare limited

amanta healthcare limited

AMANTA • ISIN: INE084K01015

BSE, NSE

Listing Price: ₹135

+7.14% Gain
About Company

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.

The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.

The company markets products through three business units:


National sales,
International sales and
Product partnering with various foreign and Indian pharmaceutical companies.


The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.

The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.

As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.

 

Competitive Strengths


Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
Large manufacturing capabilities
Wide Domestic and International Marketing Network.

Experienced management team supported by a large, diverse and skilled workforce.

Investment Objective

Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat

Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat

General corporate purposes

₹120 to ₹126

Price Band

15.0K

Min Investment

119 shares

Lot Size

46.59x

P/E Ratio

Important Dates

Issue Opens

1 Sept 2025

Issue Closes

3 Sept 2025

Allotment

4 Sept 2025

Listing

9 Sept 2025

Subscription Status
QII

Qualified Institutional Investors

28.93x

57,851,136 / 2,000,000 shares

HNI (>₹10L)

High Networth Individuals (Above ₹10 Lakhs)

158.99x

158,988,879 / 1,000,000 shares

NII (<₹10L)

Non-Institutional Investors (Below ₹10 Lakhs)

113.16x

56,580,216 / 500,000 shares

Retail

Retail Individual Investors

34.86x

122,010,581 / 3,500,000 shares

Financial Performance
Offer Documents
RHP
Visit
DHRP
Visit
Issue Details
Issue TypeBB
Face Value₹10
Lead ManagersBeeline Capital Advisors Pvt.Ltd.
Min Quantity119
Max Quantity3,968
Company Promoters
Bhavesh Patel
Vishal Patel
Jayshreeben Patel
+2 more
Website

https://www.amanta.co.in/

Email

cs@amanta.co.in

Phone079 67777600
Address

Amanta Healthcare Ltd.
8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058